Discover How to Stay Ahead
Our 133-page report provides 129 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Smart Pill market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are forecasts for 3 Smart Pill Applications in the report at a global level:
Global Smart Pill Market by Application
• Capsule Endoscopy
• Drug Delivery
• Patient Monitoring
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 major regional and 17 major national markets:
• North America:
• The US
• Canada
• Mexico
• South America:
• Brazil
• Argentina
• Bolivia
• Paraguay
• Rest of South America
• Europe:
• Germany
• The UK
• Italy
• France
• Spain
• Rest of Europe
• Asia-Pacific:
• China
• India
• Japan
• Thailand
• Australia
• Rest of Asia-Pacific
• Middle East:
• Africa
• Other Countries (Rest of World)
The report also includes profiles and for some of the leading companies in the Smart Pill market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, the US, the UK and the APAC region in particular, will continue to achieve high revenue growth to 2027.
Leading companies and the potential for market growth
Overall world revenue for Smart Pill will surpass $2.4bn in 2017, our work calculates. We predict strong revenue growth through to 2027.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Smart Pill Market report helps you
In summary, our 133-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for the Smart Pill market, with forecasts for 3 applications and 6 key regional and 17 major national markets – See forecasts for the Smart Pill market in North America, South America, Europe, Asia-Pacific, the Middle east and Africa, as well as the US, Canada, Mexico, Brazil, Argentina, Paraguay, Bolivia, Germany, France, the UK, Italy, France, Japan, China, India, Thailand and Australia.
• What stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market – including company profiles for some of the major companies involved in the Smart Pill market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Smart Pill market and leading companies. You will find data, trends and predictions.
Get our report today Smart Pill Market World Market Forecast 2017-2027: See Prospects for Capsule Endoscopy, Drug Delivery and Patient Monitoring in North America, South America, Europe, Asia-Pacific and the Rest of the World.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Smart Pill Market Overview
1.2 Research Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.2.3 Market Evaluation & Forecasting Methodology
1.3 Global Smart Pill Market Segmentation
1.4 Overview of Findings
1.5 Why You Should Read This Report
1.6 How This Report Delivers
1.7 Key Questions Answered by This Analytical Report
1.8 Frequently Asked Questions (FAQ)
1.9 Who is This Report For?
1.10 Associated Visiongain Reports
1.11 About Visiongain
2. Introduction to the Smart Pill Market
3. Smart Pill Market Forecast to 2027
4. Smart Pill Market by Application: Market Forecast to 2027
4.1 Overview
4.2 Capsule Endoscopy
4.3 Drug Delivery
4.4 Patient Monitoring
5. Regional Smart Pill Market Forecasts to 2027
5.1 Regional Smart Pill Market Forecast 2017-2027
5.2 North American Smart Pill Market Forecast 2017-2027
5.2.1 USA Smart Pill Market Forecast 2017-2027
5.2.2 Canada Smart Pill Market Forecast 2017-2027
5.2.3 Mexico Smart Pill Market Forecast 2017-2027
5.3 South American Smart Pill Market Forecast 2017-2027
5.3.1 Brazil Smart Pill Market Forecast 2017-2027
5.3.2 Argentina Smart Pill Market Forecast 2017-2027
5.3.3 Paraguay Smart Pill Market Forecast 2017-2027
5.3.4 Bolivia Smart Pill Market Forecast 2017-2027
5.3.5 Rest of South America Smart Pill Market Forecast 2017-2027
5.4 European Smart Pill Market Forecast 2017-2027
5.4.1 France Smart Pill Market Forecast 2017-2027
5.4.2 Germany Smart Pill Market Forecast 2017-2027
5.4.3 UK Smart Pill Market Forecast 2017-2027
5.4.4 Spain Smart Pill Market Forecast 2017-2027
5.4.5 Italy Smart Pill Market Forecast 2017-2027
5.4.6 Rest of Europe Smart Pill Market Forecast 2017-2027
5.5 Asia-Pacific Smart Pill Market Forecast 2017-2027
5.5.1 China Smart Pill Market Forecast 2017-2027
5.5.2 Japan Smart Pill Market Forecast 2017-2027
5.5.3 India Smart Pill Market Forecast 2017-2027
5.5.4 Australia Smart Pill Market Forecast 2017-2027
5.5.5 Thailand Smart Pill Market Forecast 2017-2027
5.5.6 Rest of Asia-Pacific Smart Pill Market Forecast 2017-2027
5.6 Rest of World Smart Pill Market Forecast 2017-2027
5.6.1 Middle East Smart Pill Market Forecast 2017-2027
5.6.2 Africa Smart Pill Market Forecast 2017-2027
5.6.3 Other Countries Smart Pill Market Forecast 2017-2027+
6. Smart Pill Market, Qualitative Analysis, 2017-2027
6.1 Porter’s Five Forces Analysis of the Smart Pill Market 2017-2027
6.1.1 Bargaining Power of Buyers (Low)
6.1.2 Bargaining Power of Suppliers (Medium)
6.1.3 Threat of New Entrants (Low)
6.1.4 Threat of Substitute Products (Medium)
6.1.5 Intensity of Competitive Rivalry (Low)
6.2 Drivers
6.2.1 Increasing Incidence of GI Disease
6.2.2 Growing Geriatric Population
6.2.3 Technological Advancement
6.2.4 Increasing Acceptance in GI Disease
6.3 Restraints
6.3.1 High Cost Associated With Capsule Endoscopy Procedures And Equipment
6.3.2 Uncertain Reimbursement Policies
6.4 Opportunities
6.4.1 Untapped Market In Developed And Developing Economies
6.4.2 Expansion In Therapeutic Application
7. Leading Companies in Smart Pill Market
7.1 Cerner Corporation
7.1.1 Cerner Corporation: Company Overview
7.1.2 Cerner Corporation: Product Portfolio
7.1.3 Cerner Corporation: Recent Developments
7.2 GE Healthcare
7.2.1 GE Healthcare: Company Overview
7.2.2 GE Healthcare: Product Portfolio
7.2.3 GE Healthcare: Recent Development
7.3 Proteus Digital Health, Inc
7.3.1 Proteus Digital Health, Inc: Company Overview
7.3.2 Proteus Digital Health, Inc: Recent Developments
7.4 Boston Scientific Corporation
7.4.1 Boston Scientific Corporation: Company Overview
7.4.2 Boston Scientific Corporation: Product Portfolio
7.4.3 Boston Scientific Corporation: Recent Developments
7.5 Capso Vision Inc.
7.5.1 Capso Vision Inc.: Company Overview
7.5.2 Capso Vision Inc.: Recent Developments
7.6 Fujifilm Holdings Corporation
7.6.1 Fujifilm Holdings Corporation: Company Overview
7.6.2 Fujifilm Holdings Corporation: Product Portfolio
7.6.3 Fujifilm Holdings Corporation: Recent Developments
7.7 Medtronic PLC
7.7.1 Medtronic PLC: Company Overview
7.7.2 Medtronic PLC: Product Portfolio
7.7.3 Medtronic PLC: Recent Developments
7.8 Bio-Images Drug Delivery Limited (BDD)
7.8.1 Bio-Images Drug Delivery Limited (BDD): Company Overview
7.9 Hoya Corporation (PENTAX MEDICAL)
7.9.1 Hoya Corporation: Company Overview
7.9.2 Hoya Corporation: Product Portfolio
7.9.3 Hoya Corporation: Recent Developments
7.10 Olympus Corporation
7.10.1 Olympus Corporation: Company Overview
7.10.2 Olympus Corporation: Product Portfolio
7.11 Other Companies of Interest in the Smart Pill Market
8. Conclusions
8.1 Current Leading Segments
8.2 Leading Regional Markets
8.3 Emerging Markets
8.4 The Future of the Market?
9. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
List of Figures
Figure 3.1 Smart Pill Market, by Type, ($m), 2017-2027
Figure 4.1 Smart Pill Market, by Application, Market Share (%), 2016
Figure 4.2 Smart Pill Market, by Application, Forecast ($m) 2017-2027
Figure 4.3 Global Capsule Endoscopy for Smart Pill Market Forecast, by Geography, ($m) 2017-2027
Figure 4.4 Global Drug Delivery for Smart Pill Market Forecast, by Geography, ($m) 2017-2027
Figure 4.5 Global Patient Monitoring for Smart Pill Market Forecast, by Geography, ($m) 2017-2027
Figure 5.1 Global Smart Pill Market Forecast, by Geography, by Geography ($m) 2017-2027
Figure 5.2 Global Smart Pill Market Forecast, by Geography, Market Share (%), 2016
Figure 5.3 North America Smart Pill Market Forecast, by Country ($m) 2017-2027
Figure 5.4 North America Smart Pill Market, by Country, Market Share (%), 2016
Figure 5.5 USA Smart Pill Market Forecast ($m) 2017-2027
Figure 5.6 Smart Pill Market Forecast ($m) 2017-2027
Figure 5.7 Mexico Smart Pill Market Forecast ($m) 2017-2027
Figure 5.8 South America Smart Pill Market Forecast, by Country ($m) 2017-2027
Figure 5.9 South America Smart Pill Market, by Country, Market Share (%), 2016
Figure 5.10 Brazil Smart Pill Market Forecast ($m) 2017-2027
Figure 5.11 Argentina Smart Pill Market Forecast ($m) 2017-2027
Figure 5.12 Paraguay Smart Pill Market Forecast ($m) 2017-2027
Figure 5.13 Bolivia Smart Pill Market Forecast ($m) 2017-2027
Figure 5.14 Rest of South America Smart Pill Market Forecast ($m) 2017-2027
Figure 5.15 Europe Smart Pill Market Forecast, by Country ($m) 2017-2027
Figure 5.16 Europe Smart Pill Market, by Country, Market Share (%), 2016
Figure 5.17 France Smart Pill Market Forecast ($m) 2017-2027
Figure 5.18 Germany Smart Pill Market Forecast ($m) 2017-2027
Figure 5.19 UK Smart Pill Market Forecast ($m) 2017-2027
Figure 5.20 Spain Smart Pill Market Forecast ($m) 2017-2027
Figure 5.21 Italy Smart Pill Market Forecast ($m) 2017-2027
Figure 5.22 Rest of Europe Smart Pill Market Forecast ($m) 2017-2027
Figure 5.23 Asia-Pacific Smart Pill Market Forecast, by Country ($m) 2017-2027
Figure 5.24 Asia-Pacific Smart Pill Market, Market Share (%), 2016
Figure 5.25 China Smart Pill Market Forecast ($m) 2017-2027
Figure 5.26 Japan Smart Pill Market Forecast ($m) 2017-2027
Figure 5.27 India Smart Pill Market Forecast ($m) 2017-2027
Figure 5.28 Australia Smart Pill Market Forecast ($m) 2017-2027
Figure 5.29 Thailand Smart Pill Market Forecast ($m) 2017-2027
Figure 5.30 Rest of Asia-Pacific Smart Pill Market Forecast ($m) 2017-2027
Figure 5.31 RoW Smart Pill Market Forecast, by Country ($m) 2017-2027
Figure 5.32 Rest of World Smart Pill Market, by Country, Market Share (%), 2016
Figure 5.33 Middle East Smart Pill Market Forecast ($m) 2017-2027
Figure 5.34 Africa Smart Pill Market Forecast ($m) 2017-2027
Figure 5.35 Other Countries Smart Pill Market Forecast ($m) 2017-2027
Figure 6.1 Porter’s Five Forces Analysis of the Smart Pill Market
Figure 7.1 Cerner Corporation, Revenue, ($million), 2012-2016
Figure 7.2 Cerner Corporation, Product Segments Share (%), 2016
Figure 7.3 GE Healthcare, Revenue, ($million), 2012-2016
Figure 7.4 GE Healthcare, Product Segments Share (%), 2016
Figure 7.5 GE Healthcare, Geographical Presence Share (%), 2016
Figure 7.6 Boston Scientific Corporation, Revenue, ($million), 2012-2016
Figure 7.7 Boston Scientific Corporation, Product Segments Share (%), 2016
Figure 7.8 Boston Scientific Corporation, Geographical Presence Share (%), 2016
Figure 7.9 Fujifilm Holdings Corporation, Revenue, ($million), 2012-2016
Figure 7.10 Fujifilm Holdings Corporation, Product Segments Share (%), 2016
Figure 7.11 Fujifilm Holdings Corporation, Geographical Presence Share (%), 2016
Figure 7.12 Medtronic PLC, Revenue, ($million), 2012-2016
Figure 7.13 Medtronic PLC, Product Segments Share (%), 2016
Figure 7.14 Medtronic PLC, Geographical Presence Share (%), 2016
Figure 7.15 Hoya Corporation, Revenue, ($million), 2014-2017
Figure 7.16 Hoya Corporation, Product Segments Share (%), 2016
Figure 7.17 Hoya Corporation, Geographical Presence Share (%), 2016
Figure 7.18 Olympus corporation, Revenue, ($million), 2013-2017
Figure 7.19 Olympus corporation, Product Segments Share (%), 2017
Figure 7.20 Olympus corporation, Geographical Presence Share (%), 2017
Figure 8.1 World Smart Pill, by Type, ($m), 2017-2027
Figure 8.2 World Smart Pill, by Geography, ($m), 2017-2027
List of Tables
Table 3.1. Smart Pill Market Forecast ($m, AGR%, CAGR%) 2017-2027
Table 4.1. Smart Pill Market Forecast, by Application ($m, AGR%, CAGR%) 2017-2027
Table 4.2 Global Capsule Endoscopy for Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 4.3 Global Capsule Endoscopy for Smart Pill Market Forecast, by Geography, ($m, AGR%, CAGR%) 2017-2027
Table 4.4 Global Drug Delivery for Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 4.5 Global Drug Delivery for Smart Pill Market Forecast, by Geography ($m, AGR%, CAGR%) 2017-2027
Table 4.6 Global Patient Monitoring for Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 4.7 Global Patient Monitoring for Smart Pill Market Forecast, by Geography ($m, AGR%, CAGR%) 2017-2027
Table 5.1 Smart Pill Market Forecast, by Geography ($m, AGR%, CAGR%) 2017-2027
Table 5.2 FDA Approved Capsule Endoscopes
Table 5.3 North America Smart Pill Market Forecast, by Country ($m, AGR%, CAGR%) 2017-2027
Table 5.4 USA Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.5 Canada Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.6 Mexico Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.7 South America Smart Pill Market Forecast, by Country ($m, AGR%, CAGR%) 2017-2027
Table 5.8 Brazil Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.9 Argentina Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.10 Paraguay Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.11 Bolivia Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.12 Rest of South America Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.13 EC Marked Capsule Endoscopy Systems
Table 5.14 European Smart Pill Market Forecast, by Country ($m, AGR%, CAGR%) 2017-2027
Table 5.15 France Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.16 Germany Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.17 UK Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.18 Spain Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.19 Italy Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.20 Rest of European Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.21 Asia-Pacific Smart Pill Market Forecast, by Country ($m, AGR%, CAGR%) 2017-2027
Table 5.22 China Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.23 Japan Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.24 India Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.25 Australia Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.26 Thailand Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.27 Rest of Asia-Pacific Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.28 Rest of World Smart Pill Market Forecast, by Country ($m, AGR%, CAGR%) 2017-2027
Table 5.29 Middle East Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.30 Africa Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 5.31 Other Countries Smart Pill Market Forecast, ($m, AGR%, CAGR%) 2017-2027
Table 7.1 Cerner Corporation: Company Overview
Table 7.2 Cerner Corporation: Product Portfolio
Table 7.3 Cerner Corporation: Recent Developments
Table 7.4 GE Healthcare: Company Overview
Table 7.5 GE Healthcare: Product Portfolio
Table 7.6 GE Healthcare: Recent Development
Table 7.7 Proteus Digital Health, Inc: Company Overview
Table 7.8 Proteus Digital Health, Inc: Recent Developments
Table 7.9 Boston Scientific Corporation: Company Overview
Table 7.10 Boston Scientific Corporation: Product Portfolio
Table 7.11 Boston Scientific Corporation: Recent Developments
Table 7.12 Capso Vision Inc.: Company Overview
Table 7.13 Capso Vision Inc.: Recent Developments
Table 7.14 Fujifilm Holdings Corporation: Company Overview
Table 7.15 Fujifilm Holdings Corporation: Product Portfolio
Table 7.16 Fujifilm Holdings Corporation: Recent Developments
Table 7.17 Medtronic PLC: Company Overview
Table 7.18 Medtronic PLC: Product Portfolio
Table 7.19 Medtronic PLC: Recent Developments
Table 7.20 Bio-Image Drug Delivery (BDD)oration: Company Overview
Table 7.21 Hoya Corporation: Company Overview
Table 7.22 Hoya Corporation: Product Portfolio
Table 7.23 Hoya Corporation: Recent Developments
Table 7.24 Olympus corporation: Company Overview
Table 7.25 Olympus corporation: Product Portfolio
Table 7.26 Other Companies for Smart Pill Market
Abbott Laboratories
AbbVie, Inc.
Alkermes Plc
Amarin Corp. Plc
Amgen, Inc.
Amnis Corporation
Array BioPharma, Inc.
Associates Of Cape Cod Inc.
Astex Pharmaceuticals Inc.
AstraZeneca Plc
ASYMPTOTE LTD
Bayer AG
Bayer Corporation
Bayer HealthCare AG
Bayer Schering Pharma Aktiengesellschaft
BioLife Solutions, Inc.
BioMarin Pharmaceutical, Inc.
Biotest AG
Bristol-Myers Squibb Co.
Cardax, Inc.
Cardinal Health, Inc.
Ceapro, Inc.
Celgene Corp.
Cephalon, Inc.
Chugai Pharmaceutical Co., Ltd.
CK Life Sciences International (Holdings), Inc.
Consensys Imaging Service Inc.
Cornerstone Research & Development Inc.
Crescendo Bioscience, Inc.
CTI BioPharma Corp.
Deroyal Industries Inc.
Domain Therapeutics SA
Emd Millipore Corporation
Emd Serono Inc.
Endo International Plc
Evotec AG
Galderma Sa
GE Healthcare LTD
GlaxoSmithKline Plc
Henry Schein, Inc.
Hoya Corporation
Illumina, Inc.
Institut Bergonie
Janssen Biotech, Inc.
JHL Biotech, Inc.
Johnson & Johnson
Laboratoire Theramex
Laboratory Corp. of America Holdings
LifeWatch AG
Lombard Medical, Inc.
Lonza Group AG
McKesson Corp.
Medline Industries Inc.
Medtronic Plc
Merck KGaA
MorphoSys AG
Motion Picture And Television Fund
Myrexis, Inc.
Myriad Genetics, Inc.
NBTY, Inc.
Neptune Technologies & Bioresources, Inc.
Nexvet Biopharma PLC
Northwell Health Inc.
Novartis AG
Olympus Corporation
Opexa Therapeutics, Inc.
Otsuka Pharmaceutical Co. Ltd.
Owens & Minor, Inc.
Panacos Pharmaceuticals, Inc.
PELICAN HEALTHCARE LTD
Pfizer Inc.
Pharma Mar SA
Polymer Technology Systems Inc.
Progyny Inc.
Quanterix Corp.
Quest Diagnostics, Inc.
Smith & Nephew Plc
Spectrum Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc.
Windtree Therapeutics, Inc.
Organisations Mentioned in this Report
European Medicines Agency
Food and Drug Administration (U S)
Ministry of Health, Labor and Welfare
National Cancer Institute
National Health Service (UK)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
